Current Health
Current Health provides an FDA-cleared AI-enabled remote patient monitoring platform and 24/7 clinical command center that enables health systems, academic medical centers, life sciences companies, and community oncology practices to safely deliver CAR-T, bispecific antibodies, and high-acuity care in outpatient and home settings.
- Company typePrivate
- Founded2014
- HeadquartersBoston, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Current Health does
Current Health is a Boston-headquartered (with engineering in Edinburgh) digital health company that provides an AI-enabled remote patient monitoring platform for delivering high-acuity care and advanced therapies (CAR-T and bispecific antibodies) in outpatient and home settings. Its core technology combines an FDA Class II 510(k)-cleared proprietary upper-arm wearable that passively tracks five vital signs with machine learning algorithms validated in a JCI Insight publication to detect cytokine release syndrome a median of 7 hours earlier than standard of care. The platform is supported by a 24/7 Clinical Command Center staffed by ED- and ICU-trained nurses licensed in all 50 states, bi-directional integration with Epic, Cerner, and Meditech, and a care operations layer that automates scheduling, route planning, and logistics.
The company serves three primary customer segments: large health systems and academic medical centers running hospital-at-home and outpatient advanced therapy programs (e.g., Mass General Brigham, Sarah Cannon/HCA, MSK, Mount Sinai, UCSF, Vanderbilt, OSF HealthCare, Baptist Health, Advocate Health, HealthFirst, Virtua, UMass Memorial); life sciences companies such as Bristol Myers Squibb that need pharmacovigilance, decentralized trial infrastructure, and RWE generation across Phase I-IV trials; and community oncology practices, physician groups, and MSOs that require turnkey infrastructure to administer CAR-T and bispecifics locally without FACT accreditation overhead. Notable clinical outcomes include 90%+ of CAR-T patients treated outpatient at Sarah Cannon, 25,000+ bed days saved at Mass General Brigham, and 89% of bispecific step-up doses successfully administered outpatient at MSK.
Current Health generates revenue through a combination of subscription-based access to the monitoring platform and FDA-cleared wearable, managed clinical services from the 24/7 Command Center, hardware sales or leases of monitoring kits, and professional services for life sciences clients. Pricing is quote-based and negotiated per enterprise program rather than publicly disclosed. The company was founded in Edinburgh in 2014, expanded to the United States in 2019, was acquired by Best Buy in 2021 for approximately $400 million, and was reacquired by its founders in 2025, who have refocused the business on advanced therapies as the primary growth driver and entered a 2026 partnership with Cardinal Health's Velocare for hospital-at-home logistics.
Current Health firmographics
Firmographics- Name
- Current Health
- Legal name
- Current Health, Inc.
- Website
- https://currenthealth.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Current Health provides an FDA-cleared AI-enabled remote patient monitoring platform and 24/7 clinical command center that enables health systems, academic medical centers, life sciences companies, and community oncology practices to safely deliver CAR-T, bispecific antibodies, and high-acuity care in outpatient and home settings.
- Ownership category
- akta.pro rank
Current Health industry classification
Industry- Product category
- Remote Patient Monitoring
- NAICS
- Home Health Care Services (621610), Home Health Care Services (62161)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Services-Home Health Care Services (8082), Services-Health Services (8000)
- akta.pro primary industry
- Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows) (HLALAFAH)
- akta.pro secondary industries
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Post-Acute & Hospital-at-Home Remote Care Platforms (HLACAFAB), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
Keywords
Where Current Health is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Current Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Technology Platform Subscription: Subscription-based access to FDA-cleared monitoring platform, clinical dashboard, AI-enabled adverse event detection, and EHR integration. Includes proprietary wearable device and connected peripherals.
- Clinical Services: 24/7 Clinical Command Center staffing by ED and ICU-trained nurses. Virtual ICANS assessments. Care coordination and operations support.
- Hardware Sales: Sale or lease of proprietary wearable devices and connected peripheral devices (temperature patches, blood pressure cuffs, scales, etc.) included in patient monitoring kits.
- Life Sciences / Clinical Trial Services: Pharmacovigilance infrastructure, decentralized trial enablement, RWE generation, and provider network services for pharma companies conducting Phase I-IV clinical trials on advanced therapies.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Current Health product offering
Product offeringCore offering
Current Health provides an FDA-cleared, AI-enabled remote patient monitoring platform that combines a proprietary upper-arm wearable, passive biometric monitoring, machine learning-based adverse event detection (CRS, ICANS, sepsis), and a 24/7 Clinical Command Center staffed by ED/ICU-trained nurses. The platform is delivered to health systems, academic medical centers, community oncology practices, and life sciences companies to enable safe delivery of high-acuity care and advanced therapies (CAR-T, bispecifics) in outpatient and home settings.
Product overview
Current Health offers a unified platform combining FDA-cleared technology, AI-enabled clinical intelligence, and 24/7 nursing support for delivering complex care beyond the hospital. The portfolio centers on the Current Health wearable and Passive Remote Monitoring Platform with AI-Enabled Adverse Event Detection, supported by the 24/7 Clinical Command Center and Care Operations Platform. Service offerings span four models: High-Acuity Care at Home for hospital-at-home programs; Advanced Therapies for Health Systems and Community Clinics for outpatient CAR-T and bispecifics delivery; and Life Sciences for clinical trial enablement. All components integrate with major EHR systems (Epic, Cerner, Meditech) and are supported by Expert Consulting Services for program design and payer strategy.
Differentiator
Problem solved
Functional benefit
Products and services
- Current Health Platform (Passive Remote Monitoring Platform)
- Current Health Wearable
- Home Hub and Tablet Kit
- Connected Peripheral Device Packages
- 24/7 Clinical Command Center
- High-Acuity Care at Home Program
- Advanced Therapies Delivery Program
- Life Sciences Clinical Trial Enablement
- Expert Consulting Services
- Care Operations Platform
Quantifiable outcome
- 7 hours earlier CRS detection than standard of care, enabling proactive intervention
- +9 more outcomes
Companies that use Current Health
Customer profileNamed customers13 records
Segments3 records
Ideal customer profiles3 records
Current Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability6 records
Feature7 records
Current Health partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and flagship.
- Cardinal HealthcoreCardinal Health's Velocare supply chain solution partnership for end-to-end logistics in hospital-at-home programs. Collaboration handles last-mile fulfillment, kit installation, and retrieval of Current Health's in-home clinical monitoring kits. Integrates platforms to streamline patient onboarding and reduce duplicate data entry. Partnership aims to help health systems simplify operations, lower program costs, and scale acute care-at-home programs sustainably.
- BMS (Bristol Myers Squibb)flagshipStrategic partnership with BMS for outpatient advanced therapy delivery infrastructure. Partnered with leading manufacturers including BMS to move advanced therapies safely into outpatient and community settings. Early partnership in clinical development generates RWE supporting payer negotiations and enabling scaled community adoption.
- Sarah Cannon Cancer Institute (HCA Healthcare)flagshipLaunched largest multisite outpatient CAR-T program in 2023. Sarah Cannon transitioned 90%+ of CAR-T therapies to outpatient setting using Current Health's platform. Saved 1,200+ bed days in first 100 cases. Leading research partnership with multiple peer-reviewed publications in Blood and other journals.
- Mass General BrighamflagshipOne of nation's largest Hospital at Home programs demonstrating model scalability and clinical safety. Achieved 200% growth in 15 months, average daily census of 49 patients, 25K+ bed days saved. Joint case study and research publications documenting operational strategies and clinical outcomes.
- Memorial Sloan Kettering Cancer CentercoreClinical research partnership on outpatient bispecific antibody delivery. 89% of patients successfully received step-up doses of Teclistamab and Talquetamab at outpatient setting. Research published in ASH Blood Advances demonstrating safety of outpatient step-up dosing protocols.
- Mount SinaicoreClinical research collaboration on wearable monitoring for outpatient CAR-T. Prospective trial published in JCI Insight showing 7-hour median lead time for CRS detection vs. standard nursing care. Validates Current Health platform's early detection capabilities.
- UCSF HealthcorePartnership for migrating advanced therapies to outpatient settings. Joint webinar on operational insights for outpatient CAR-T and bispecific pathways. Clinical leaders sharing experience on program building, patient flow, and provider engagement.
Scale indicators16 records
Recent moves9 records
Expansion highlights6 records
Current Health competitors and assessment
Company assessmentDirect peers
- Cadence: Hospital-at-home technology and care model provider partnering with large health systems to deliver acute care at home. Directly competes for the same HaH RFPs that Mass General Brigham, Advocate, and other Current Health customers represent.
- VitalConnect: Provider of a clinical-grade wearable biosensor (VitalPatch) and RPM platform used for hospital-at-home and ambulatory monitoring. Competes head-to-head with Current Health's proprietary wearable for continuous multi-vital monitoring in post-acute and acute care at home.
- Biofourmis: Boston-based AI-enabled RPM and hospital-at-home platform with FDA-cleared algorithms. Targets similar health-system customers and shares the playbook of combining wearable monitoring, predictive analytics, and care coordination - the closest direct competitor to Current Health.
- Vivify Health (Optum / UnitedHealth Group): Pioneer in RPM and connected health platforms, now part of Optum. Competes in chronic and post-acute RPM with enterprise health system deployments analogous to Current Health's customer base.
- Health Recovery Solutions (HRS): RPM and patient engagement platform deployed across hundreds of US health systems for chronic care and post-acute management. Overlaps with Current Health on hospital-at-home programs and chronic-disease monitoring use cases.
Emerging players
- Medable: Decentralized clinical trial platform partnered with pharma sponsors for remote monitoring and eCOA/ePRO. Overlaps with Current Health's Life Sciences/clinical-trial business line for pharma trial infrastructure.
Broad incumbents
- Masimo: Public patient monitoring company with FDA-cleared wearable sensors (e.g., MightySat, Radius PPG) and continuous monitoring offerings. A broader incumbent moving into ambulatory, hospital, and home monitoring - an adjacent threat in the clinical-grade wearable space.
- Medtronic (Cardiac Diagnostics / LINQ family): Large device manufacturer with cardiac remote monitoring (LINQ, CareLink) serving millions of patients. Has the regulatory, manufacturing, and hospital relationships to expand into general RPM and compete with Current Health for cardiology-adjacent and general ward telemetry use cases.
- Philips (HealthSuite / RPM): Diversified medtech incumbent with RPM, hospital telehealth, and care-at-home solutions across its HealthSuite platform. Competes broadly in health-system RPM purchases, though not as specialized in advanced-therapy delivery.
- GE Healthcare: Major imaging and patient monitoring vendor increasingly bundling RPM and command-center capabilities. Targets the same acute-care-at-home and centralized monitoring RFPs as Current Health's Clinical Command Center.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Current Health social profiles
Digital presenceCurrent Health compliance and trust
Trust signalCompliance6 records
Current Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Current Health leadership team
Management profileNumber of profiles
Profiles13 records
Current Health funding detail
Funding detailFunding overview
Funding rounds11 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Current Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Current Health
What does Current Health do?
Current Health provides an FDA-cleared, AI-enabled remote patient monitoring platform that combines a proprietary upper-arm wearable, passive biometric monitoring, machine learning-based adverse event detection (CRS, ICANS, sepsis), and a 24/7 Clinical Command Center staffed by ED/ICU-trained nurses. The platform is delivered to health systems, academic medical centers, community oncology practices, and life sciences companies to enable safe delivery of high-acuity care and advanced therapies (CAR-T, bispecifics) in outpatient and home settings.
Is Current Health a public or private company?
Current Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Current Health founded?
Current Health was founded in 2014. It employs 101 to 250 people.
Where is Current Health based?
Current Health is headquartered in Boston, United States, in the North America region.
How does Current Health make money?
Four revenue lines are on record. Technology Platform Subscription is the primary driver. The others are clinical Services, hardware Sales and life Sciences / Clinical Trial Services.
Who are Current Health's main competitors?
Direct peers on record are Cadence, VitalConnect, Biofourmis, Vivify Health (Optum / UnitedHealth Group) and Health Recovery Solutions (HRS). Medable is listed as an emerging player. Broad incumbents are Masimo, Medtronic (Cardiac Diagnostics / LINQ family), Philips (HealthSuite / RPM) and GE Healthcare.
Does Current Health have an API?
No public API is recorded for Current Health.
What industry is Current Health in?
Current Health's product category is Remote Patient Monitoring. Its primary akta.pro industry code is HLALAFAH, Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 621610 and its SIC code is 3841.